Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 245

1.

Cholesterol absorption inhibitors in the treatment of hyperlipidemia: clinical outcomes in large clinical trials.

Kesäniemi A.

Fundam Clin Pharmacol. 2007 Nov;21 Suppl 2:29-30. Review.

PMID:
18001318
2.

Ezetimibe plus simvastatin cardiovascular outcomes study program.

Padial LR.

Expert Rev Cardiovasc Ther. 2008 Jan;6(1):17-25. Review.

PMID:
18095904
3.

Simvastatin with or without ezetimibe in familial hypercholesterolemia.

Eichhorn EJ.

N Engl J Med. 2008 Jul 31;359(5):529-30; author reply 532. No abstract available.

PMID:
18677795
4.

Simvastatin with or without ezetimibe in familial hypercholesterolemia.

Connor WE.

N Engl J Med. 2008 Jul 31;359(5):530; author reply 532-3. No abstract available.

PMID:
18677797
5.

[Hyperlipidemia: therapeutic principles in clinical practice].

Müller-Wieland D, Krone W.

Med Klin (Munich). 2003 Dec 15;98(12):739-43. Review. German.

PMID:
14685674
6.

Simvastatin with or without ezetimibe in familial hypercholesterolemia.

Steinberg D.

N Engl J Med. 2008 Jul 31;359(5):529; author reply 532. doi: 10.1056/NEJMc080981. No abstract available.

7.

After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.

Mascitelli L, Ravnskov U, Pezzetta F, Goldstein MR.

Angiology. 2009 Feb-Mar;60(1):127-8; author reply 129-30. doi: 10.1177/0003319708327788. Epub 2008 Dec 1. No abstract available.

PMID:
19049996
8.

Setting a new standard in achieving superior efficacy: ezetimibe + simvastatin.

Farnier M.

Fundam Clin Pharmacol. 2007 Nov;21 Suppl 2:27-8. Review.

PMID:
18001317
9.

Efficacy and safety of ezetimibe/simvastatin association on non-diabetic and diabetic patients with polygenic hypercholesterolemia or combined hyperlipidemia and previously intolerant to standard statin treatment.

Derosa G, D'Angelo A, Franzetti IG, Ragonesi PD, Gadaleta G, Scalise F, Ciccarelli L, Piccinni MN, Cicero AF.

J Clin Pharm Ther. 2009 Jun;34(3):267-76.

PMID:
19650249
10.

Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.

Guyton JR, Brown BG, Fazio S, Polis A, Tomassini JE, Tershakovec AM.

J Am Coll Cardiol. 2008 Apr 22;51(16):1564-72. doi: 10.1016/j.jacc.2008.03.003.

11.

Ezetimibe/simvastatin (INEGY) in the treatment of hyperlipidaemia.

Kastelein JJ, Sankatsing RR.

Int J Clin Pract. 2005 Dec;59(12):1464-71. Review.

PMID:
16351680
12.

[Therapy of familial hypercholesterolemia with or without ezetimibe].

Berthold HK, Nitschmann S.

Internist (Berl). 2008 Oct;49(10):1274-6. doi: 10.1007/s00108-008-2215-8. German. No abstract available.

PMID:
18754087
13.

Does ENHANCE diminish confidence in lowering LDL or in ezetimibe?

Brown BG, Taylor AJ.

N Engl J Med. 2008 Apr 3;358(14):1504-7. doi: 10.1056/NEJMe0801608. Epub 2008 Mar 30. No abstract available.

14.

Is there a problem with ezetimibe or just ENHANCEd hype?

Whayne TF Jr.

Angiology. 2008 Dec-2009 Jan;59(6):661-3. doi: 10.1177/0003319708321188. Epub 2008 Sep 15. No abstract available.

PMID:
18796445
15.
17.

Simvastatin with or without ezetimibe in familial hypercholesterolemia.

Blake JA.

N Engl J Med. 2008 Jul 31;359(5):531; author reply 532-3. No abstract available.

PMID:
18677798
18.

Ezetimibe--an update.

[No authors listed]

Drug Ther Bull. 2009 Aug;47(8):91-5. doi: 10.1136/dtb.2009.07.0030. Review.

PMID:
19654419
19.

Cholesterol lowering and ezetimibe.

Drazen JM, Jarcho JA, Morrissey S, Curfman GD.

N Engl J Med. 2008 Apr 3;358(14):1507-8. doi: 10.1056/NEJMe0801842. Epub 2008 Mar 30. No abstract available.

20.

Supplemental Content

Support Center